339 related articles for article (PubMed ID: 18334280)
41. Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
Sakai M; Kato H; Sano A; Tanaka N; Inose T; Kimura H; Sohda M; Nakajima M; Kuwano H
Ann Surg Oncol; 2009 Sep; 16(9):2494-501. PubMed ID: 19526206
[TBL] [Abstract][Full Text] [Related]
42. Detection of autoantibodies against cyclophilin A and triosephosphate isomerase in sera from breast cancer patients by proteomic analysis.
Tamesa MS; Kuramitsu Y; Fujimoto M; Maeda N; Nagashima Y; Tanaka T; Yamamoto S; Oka M; Nakamura K
Electrophoresis; 2009 Jun; 30(12):2168-81. PubMed ID: 19582718
[TBL] [Abstract][Full Text] [Related]
43. SELDI-TOF MS proteinchip technology for screening of serum markers of HBV-induced hepatocellular carcinoma.
Geng X; Wang F; Li YG; Zhu GP; Zhang WM
J Exp Clin Cancer Res; 2007 Dec; 26(4):505-8. PubMed ID: 18365545
[TBL] [Abstract][Full Text] [Related]
44. MALDI-TOF/TOF-MS reveals elevated serum haptoglobin and amyloid A in Behcet's disease.
Mao L; Dong H; Yang P; Zhou H; Huang X; Lin X; Kijlstra A
J Proteome Res; 2008 Oct; 7(10):4500-7. PubMed ID: 18754684
[TBL] [Abstract][Full Text] [Related]
45. Cancer cell-secreted proteomes as a basis for searching potential tumor markers: nasopharyngeal carcinoma as a model.
Wu CC; Chien KY; Tsang NM; Chang KP; Hao SP; Tsao CH; Chang YS; Yu JS
Proteomics; 2005 Aug; 5(12):3173-82. PubMed ID: 16035111
[TBL] [Abstract][Full Text] [Related]
46. Membrane proteomic analysis comparing squamous cell lung cancer tissue and tumour-adjacent normal tissue.
Li B; Chang J; Chu Y; Kang H; Yang J; Jiang J; Ma H
Cancer Lett; 2012 Jun; 319(1):118-24. PubMed ID: 22252117
[TBL] [Abstract][Full Text] [Related]
47. Prevalence and clinical significance of anticardiolipin, anti-beta2-glycoprotein-1, and anti-heat shock protein-70 autoantibodies in sudden sensorineural hearing loss.
Gross M; Eliashar R; Ben-Yaakov A; Ulmansky R; Elidan J
Audiol Neurootol; 2008; 13(4):231-8. PubMed ID: 18259075
[TBL] [Abstract][Full Text] [Related]
48. Identification of differentially expressed, tumor-associated proteins in oral squamous cell carcinoma by proteomic analysis.
Turhani D; Krapfenbauer K; Thurnher D; Langen H; Fountoulakis M
Electrophoresis; 2006 Apr; 27(7):1417-23. PubMed ID: 16568407
[TBL] [Abstract][Full Text] [Related]
49. Mass profiling-directed isolation and identification of a stage-specific serologic protein biomarker of advanced prostate cancer.
Lam YW; Mobley JA; Evans JE; Carmody JF; Ho SM
Proteomics; 2005 Jul; 5(11):2927-38. PubMed ID: 15952230
[TBL] [Abstract][Full Text] [Related]
50. [Immuno-proteomic screening of human pancreatic cancer associated membrane antigens for early diagnosis].
Ning L; Pan B; Zhao YP; Liao Q; Zhang TP; Chen G; Wang WB; Yang YC
Zhonghua Wai Ke Za Zhi; 2007 Jan; 45(1):34-8. PubMed ID: 17403287
[TBL] [Abstract][Full Text] [Related]
51. A novel approach using MALDI-TOF/TOF mass spectrometry and prestructured sample supports (AnchorChip Technology) for proteomic profiling and protein identification.
Leung SM; Pitts RL
Methods Mol Biol; 2008; 441():57-70. PubMed ID: 18370311
[TBL] [Abstract][Full Text] [Related]
52. IPO-38 is identified as a novel serum biomarker of gastric cancer based on clinical proteomics technology.
Hao Y; Yu Y; Wang L; Yan M; Ji J; Qu Y; Zhang J; Liu B; Zhu Z
J Proteome Res; 2008 Sep; 7(9):3668-77. PubMed ID: 18680356
[TBL] [Abstract][Full Text] [Related]
53. Serum peptidome profiling revealed platelet factor 4 as a potential discriminating Peptide associated with pancreatic cancer.
Fiedler GM; Leichtle AB; Kase J; Baumann S; Ceglarek U; Felix K; Conrad T; Witzigmann H; Weimann A; Schütte C; Hauss J; Büchler M; Thiery J
Clin Cancer Res; 2009 Jun; 15(11):3812-9. PubMed ID: 19470732
[TBL] [Abstract][Full Text] [Related]
54. Serum anti-myomegalin antibodies in patients with esophageal squamous cell carcinoma.
Shimada H; Kuboshima M; Shiratori T; Nabeya Y; Takeuchi A; Takagi H; Nomura F; Takiguchi M; Ochiai T; Hiwasa T
Int J Oncol; 2007 Jan; 30(1):97-103. PubMed ID: 17143517
[TBL] [Abstract][Full Text] [Related]
55. Serum markers as predictors of esophageal squamous dysplasia and early cancer.
Chen W; Abnet CC; Wei WQ; Roth MJ; Lu N; Taylor PR; Pan QJ; Luo XM; Dawsey SM; Qiao YL
Anticancer Res; 2004; 24(5B):3245-9. PubMed ID: 15510618
[TBL] [Abstract][Full Text] [Related]
56. Autoantibodies against stress-induced phosphoprotein-1 as a novel biomarker candidate for ovarian cancer.
Kim S; Cho H; Nam EJ; Kim SW; Kim YT; Park YW; Kim BW; Kim JH
Genes Chromosomes Cancer; 2010 Jul; 49(7):585-95. PubMed ID: 20461751
[TBL] [Abstract][Full Text] [Related]
57. Serological antibodies against LY6K as a diagnostic biomarker in esophageal squamous cell carcinoma.
Zhang B; Zhang Z; Zhang X; Gao X; Kernstine KH; Zhong L
Biomarkers; 2012 Jun; 17(4):372-8. PubMed ID: 22515502
[TBL] [Abstract][Full Text] [Related]
58. Identification of tumor antigens that elicit a humoral immune response in the sera of Chinese esophageal squamous cell carcinoma patients by modified serological proteome analysis.
Gao H; Zheng Z; Mao Y; Wang W; Qiao Y; Zhou L; Liu F; He H; Zhao X
Cancer Lett; 2014 Mar; 344(1):54-61. PubMed ID: 24157810
[TBL] [Abstract][Full Text] [Related]
59. Serum amyloid A as a prognostic marker in melanoma identified by proteomic profiling.
Findeisen P; Zapatka M; Peccerella T; Matzk H; Neumaier M; Schadendorf D; Ugurel S
J Clin Oncol; 2009 May; 27(13):2199-208. PubMed ID: 19307507
[TBL] [Abstract][Full Text] [Related]
60. Potential biomarkers for esophageal carcinoma detected by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
Liu LH; Shan BE; Tian ZQ; Sang MX; Ai J; Zhang ZF; Meng J; Zhu H; Wang SJ
Clin Chem Lab Med; 2010 Jun; 48(6):855-61. PubMed ID: 20345231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]